FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24564811000001106: Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-May 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2117041000001113 Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2117051000001111 Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Is a Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Drospirenone false Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Is a Acondro true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) 63 tablet 3 x 21 tablets Has AMP True Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start